Song N. Wei
300 Guang Zhou Road
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Prognostic Value of TBC1D1 and Its Relationship With the Tumor Microenvironment in Pancreatic Cancer: A Study Based on Single-Cell Sequencing.
Journal: FASEB bioAdvances
Published: March 28, 2025
Retraction: Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway.
Journal: Oncotarget
Published: January 20, 2025
EGR2 promotes liver cancer metastasis by enhancing IL-8 expression through transcription regulation of PDK4 in M2 macrophages.
Journal: International immunopharmacology
Published: January 10, 2025
The pulmonary toxicity of e-cigarette vaping exposure and the benefits of air cleaner application
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: January 08, 2024
Discovery and Structural Optimization of Novel Quinolone Derivatives as Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors.
Journal: Journal of medicinal chemistry
Published: June 19, 2023
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions.
Journal: Frontiers in cell and developmental biology
Published: April 03, 2023
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells.
Journal: Cell reports
Published: July 20, 2022
Erratum: Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling.
Journal: iScience
Published: December 22, 2021
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells.
Journal: Cell reports
Published: September 24, 2021
Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Journal: Journal of hepatology
Published: September 12, 2021
RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α-XBP1s pathway.
Journal: Cell death discovery
Published: July 17, 2021
Last Updated: 09/26/2026